Analysis of the serological response to Chlamydia pneumoniae in patients with ischemic heart disease by recombinant MOMP-ELISA
Authors:
- Mutsunori ShiraiMSMutsunori Shirai
- Teruko NakazawaTNTeruko Nakazawa
- Kazunobu OuchiKOKazunobu Ouchi
- 1 January 2001
- journal article
- research article
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 7 (3) , 180-185
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the Caerphilly prospective heart disease study Commentary: Chlamydia pneumoniae infection and ischaemic heart diseaseBMJ, 1999
- A Review of and AtherosclerosisEuropean Journal of Vascular and Endovascular Surgery, 1999
- Pathogenesis of atherosclerosis: a possible relation to infectionAtherosclerosis, 1998
- Chlamydia pneumoniae in coronary and iliac arteries of Japanese patients with atherosclerotic cardiovascular diseasesJournal of Medical Microbiology, 1998
- High Prevalence ofChlamydia pneumoniaeDNA in Peripheral Blood Mononuclear Cells in Patients with Cardiovascular Disease and in Middle‐Aged Blood DonorsThe Journal of Infectious Diseases, 1998
- Cardiovascular disease risk from prior Chlamydia pneumoniae infection can be related to certain antigens recognized in the immunoblot profileJournal of Infection, 1997
- Serological response to Chlamydia pneumoniae in patients with sarcoidosisJournal of Infection, 1996
- Chlamydia pneumoniae (TWAR)Clinical Microbiology Reviews, 1995
- Immunoreactivity of the 60 kDa cysteine-rich proteins of Chlamydia trachomatis, Chlamydia psittaci and Chlamydia pneumoniae expressed in Escherichia coliMicrobiology, 1994
- Chlamydia pneumoniae sp. nov. for Chlamydia sp. Strain TWARInternational Journal of Systematic and Evolutionary Microbiology, 1989